<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(6)</volume><submitter>Abul Hasnat M</submitter><pubmed_abstract>Chitosan nanoparticle-based drug delivery systems incorporating 4-carboxy-phenylboronic acid (PBA) have emerged as a key strategy for enhancing therapeutic efficacy by active targeting of tumor and improving drug loading capacity. Herein, we have developed a PBA-modified chitosan-based (PBA-CS) semi-interpenetrating polymer network (semi-IPN) nanoparticles (NPs) of 4-carboxy-phenylboronic acid-conjugated chitosan-poly-(1-vinylimidazole) (PBA-CS-PVIm) and 4-carboxy-phenylboronic acid-conjugated chitosan-poly-(methacrylic acid) (PBA-CS-PMAA) via free radical polymerization of 1-vinyl imidazole (VIm) and methacrylic acid (MAA), with high drug loading capacity of doxorubicin (Dox). The synthesized semi-IPN NPs were characterized using Fourier transform infrared spectroscopy (ATR-FTIR), transmi</pubmed_abstract><journal>ACS omega</journal><pagination>9003-9021</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12917645</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>pH-Responsive Semi-IPN Nanoparticles Based on 4‑Carboxyphenylboronic Acid-Modified Chitosan for Targeted and Controlled Release of Chemotherapeutic Drug.</pubmed_title><pmcid>PMC12917645</pmcid><pubmed_authors>Reza MS</pubmed_authors><pubmed_authors>Ihara H</pubmed_authors><pubmed_authors>Abul Hasnat M</pubmed_authors><pubmed_authors>Khan MN</pubmed_authors><pubmed_authors>Shikuku R</pubmed_authors><pubmed_authors>Takafuji M</pubmed_authors></additional><is_claimable>false</is_claimable><name>pH-Responsive Semi-IPN Nanoparticles Based on 4‑Carboxyphenylboronic Acid-Modified Chitosan for Targeted and Controlled Release of Chemotherapeutic Drug.</name><description>Chitosan nanoparticle-based drug delivery systems incorporating 4-carboxy-phenylboronic acid (PBA) have emerged as a key strategy for enhancing therapeutic efficacy by active targeting of tumor and improving drug loading capacity. Herein, we have developed a PBA-modified chitosan-based (PBA-CS) semi-interpenetrating polymer network (semi-IPN) nanoparticles (NPs) of 4-carboxy-phenylboronic acid-conjugated chitosan-poly-(1-vinylimidazole) (PBA-CS-PVIm) and 4-carboxy-phenylboronic acid-conjugated chitosan-poly-(methacrylic acid) (PBA-CS-PMAA) via free radical polymerization of 1-vinyl imidazole (VIm) and methacrylic acid (MAA), with high drug loading capacity of doxorubicin (Dox). The synthesized semi-IPN NPs were characterized using Fourier transform infrared spectroscopy (ATR-FTIR), transmi</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T17:59:13.506Z</modification><creation>2026-07-09T11:10:18.763Z</creation></dates><accession>S-EPMC12917645</accession><cross_references><pubmed>41726616</pubmed><doi>10.1021/acsomega.5c04836</doi></cross_references></HashMap>